What is the Impact Factor of Drug Target Insights?

According to the latest Clarivate Journal Citation Reports (JCR), the Journal Impact Factor of Drug Target Insights is 3.70, ranking in quartile Q2 of Web of Science (ESCI).

Is Drug Target Insights indexed in Web of Science or Scopus?

Yes, Drug Target Insights is indexed in Web of Science (ESCI, Q2 quartile). Furthermore, in Scopus (SCImago), it holds an SJR rating of 0.692 (Q1) and an H-index of 20.

Who publishes Drug Target Insights and what is the Article Processing Charge (APC)?

Drug Target Insights is published by AboutScience Srl. The estimated Article Processing Charge (APC) is approximately $2,962 USD, subject to institutional waivers and corresponding author affiliations.

WoS ESCI Q2Scopus Q1SCImago #8,356Hybrid

Drug Target Insights

Identifier (ISSN):1177-3928(Print)

•

Publisher:AboutScience Srl

Clarivate JCR Index Advisory: Active (ESCI)

Official Website Submission Portal Compare

Clarivate IF (2026)

3.7↑ +1.2

Journal Impact Factor

IF Trend↓

WoS Quartile

WoS ESCIJCR Quartile

Clarivate WoS JCR

WoS Categories↓

JCR Release Date: 2026-06-17

Impact Factor Trend (2023–2026)

Clarivate IF trend for Drug Target Insights

WoS Q2

Annual Impact Factor Metric

Current (2026):3.7

Scopus SJR & RankScopus Q1

0.692

#8,356

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025

H-Index (2025)

20 papers with at least that number of citations each

WoS: ESCIQ2

Self-Citation Rate5%

Safe Level (< 15%)Warning Level (> 20%)

Self-citation below 15% indicates strong scholarly independence.

Volume & Open AccessHybrid

5articles/year

94.44% Gold OA•81.82% Original Research

Aims & Scope

Drug Target Insights (ISSN: 1177-3928) is a peer-reviewed international scholarly journal in the field of PHARMACOLOGY & PHARMACY, published by AboutScience Srl in Italy. The periodical holds a Journal Impact Factor (JIF) of 3.70, ranking in quartile Q2 of Web of Science (ESCI), a Scopus SJR indicator of 0.692 (Q1), an H-index of 20.

Topics Covered (Recognized by AI)

Medicine97.2%Biology96.5%Internal medicine80.6%Genetics77.1%Chemistry72.9%Biochemistry71.5%Pathology52.8%Psychology45.1%Immunology41%Psychiatry40.3%Endocrinology38.9%Physics36.8%Pharmacology36.8%Organic chemistry33.3%Gene27.1%Receptor26.4%Nuclear magnetic resonance20.8%

Primary Research Areas

Pharmacology & Pharmacy

Official Website NLM PubMed Catalog SCImago Profile

0 calls

Special Issues

Calls for Papers

No active Calls for Papers found for this journal.

Expand

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI

JCRESCI2026

PHARMACOLOGY & PHARMACY

Rank120/356

IndexESCI

JCIESCI2026

PHARMACOLOGY & PHARMACY

Rank168/356

IndexESCI

Category	Index	Rank	Quartile
PHARMACOLOGY & PHARMACY	JCRESCI	120/356	Q2
PHARMACOLOGY & PHARMACY	JCIESCI	168/356	Q2

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year

2026Latest

IF3.7

Articles / Year5

Total Citations0

2025

IF2.5

Articles / Year11

Total Citations30

2024

IF2

Articles / Year14

Total Citations79

2023

IF2.7

Articles / Year16

Total Citations168

2022

IF—

Articles / Year13

Total Citations107

Year	Impact Factor	Articles / Year	Total Citations
2026	3.7	5	0
2025	2.5	11	30
2024	2	14	79
2023	2.7	16	168
2022	—	13	107
2021	—	5	129
2020	—	5	89
2019	—	10	269
2018	—	4	24
2017	—	7	55
2016	—	14	183
2015	—	11	112

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #8,356Scopus Q1SCImago Profile

Scopus Coverage:2008-2009, 2011-2025

•

Scopus Broad Areas:Biochemistry, Genetics and Molecular BiologyMedicinePharmacology, Toxicology and Pharmaceutics

Scopus Citation Rank (SJR)Q1

0.692

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1

Citations / Doc (2 years)

3.52

Average citations received per document published in the 2-year window.

2-Year Citation Window

Estimated Publication Fee (APC)

$2,962 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations136

3-Year Documents42

Citable Documents39

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate50.0%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Pharmacology, Toxicology and Pharmaceutics (miscellaneous)Q1

Clinical BiochemistryQ2

Medicine (miscellaneous)Q2

Pharmacology (medical)Q2

Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth

Self-citation: 5%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):

4区 (Zone 4)Medicine

Minor Category (Specific Field):

4区PHARMACOLOGY & PHARMACY

CAS Early Warning List History:

Updated annually: 2020 – 2024

2020

Not warned

2021

Not warned

2022

Not warned

2023

Not warned

2024

Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

The journal enforces rigorous peer evaluation with an annual output of approximately 5 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $2,962 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.